Results 101 to 110 of about 57,669 (284)

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study [PDF]

, 2012
<p>Background: Randomized controlled trials have shown the importance of tight glucose control in type 1 diabetes (T1DM), but few recent studies have evaluated the risk of cardiovascular disease (CVD) and all-cause mortality among adults with T1DM.
Andrew D. Morris, Donald W. M. Pearson, Eleanor J. Hothersall, Frank Sullivan, Graham P. Leese, Helen C. Looker, Helen M. Colhoun, John Chalmers, John McKnight, John R. Petrie, Naveed Sattar, Norman R. Peden, Richard Lehman, Robert S. Lindsay, Sam Philip, Sarah H. Wild, Shona J. Livingstone, Stephen Cleland   +17 more
core   +8 more sources

Islet Autoantibodies in Adult With Pituitary and Ovarian Autoimmunity: Implications for Type 1 Diabetes Screening

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Purpose Type 1 diabetes is a chronic autoimmune disease characterised by progressive pancreatic β‐cell destruction and the early appearance of islet autoantibodies (islet‐AAb) during the pre‐symptomatic phases. Given the growing interest in screening and prevention of type 1 diabetes, this study aimed to assess the prevalence of pancreatic ...
Giuseppe Bellastella, Michela di Nuzzo, Miriam Longo, Paolo Cirillo, Antonietta Maio, Nicole Di Martino, Silvia Angelino, Paola Caruso, Lorenzo Scappaticcio, Maria Teresa Vietri, Maria Ida Maiorino, Katherine Esposito   +11 more
wiley   +1 more source

Diabetic ketoacidosis knowledge in type 1 diabetes: a Brazilian perspective

Archives of Endocrinology and Metabolism
Objective: To evaluate the factors associated with knowledge of diabetic ketoacidosis among individuals with type 1 diabetes mellitus and to analyze how sociodemographic, clinical, and healthcare access variables influence understanding of the condition ...
Renan Bruno Faria Pisani, Virgínia Valiate Gonzalez, Bruna Rambo Witte, Taylane Guimarães Gonçalves, Lohane Alves Santiago, Adalgiza Mafra Moreno, Rodrigo de Azeredo Siqueira   +6 more
doaj   +1 more source

Frequency of Diabetic Ketoacidosis and Severe Hypoglycemia in Children with Type 1 Diabetes

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2022
Background and Objective: Diabetic ketoacidosis and severe hypoglycemia are common and recurrent acute complications of type 1 diabetes and are associated with high mortality and morbidity. The aim of this study was to determine the frequency of diabetic
A Homaei, F Saffari, E Parsarad, ZS Mohammadi   +3 more
doaj  

Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR‐Based β‐Cell Replacement and Treg Immune Modulation Approaches

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease marked by the destruction of pancreatic β‐cells, resulting in lifelong dependence on exogenous insulin. Despite advances in insulin delivery and glucose monitoring technologies, patients remain at risk for acute and long‐term complications, underscoring the need for ...
Tzu‐Min Lin, Hui‐Fang Chang, Tzu‐Ching Lin, Cheng‐Han Lin, Yu‐Ling Sun, Chih‐Sheng Lin   +5 more
wiley   +1 more source

Diabetic Ketoacidosis Associated with Quetiapine Treatment: A Case Report

Kerala Journal of Psychiatry, 2015
Atypical antipsychotics are known for their metabolic side effects and there have been reports of them precipitating diabetic ketoacidosis which can be even fatal.
Badr Ratnakaran, S Sethulakshmi
doaj  

Boerhaave syndrome in a paediatric patient with diabetic ketoacidosis: A case report [PDF]

Scripta Medica
Diabetic ketoacidosis is a serious and potentially life-threatening complication of type 1 diabetes mellitus (T1DM), which often results from poor glycaemic control.
Alkhalifah Yasir S.
doaj   +1 more source

Barriers and Enablers to Diabetes Technologies Use Among Individuals With Type 1 Diabetes: A Scoping Review

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Advanced diabetes technologies are standard of care for people with Type 1 diabetes (T1D). However, inequitable access contributes to disparities in outcomes. Purpose To characterise barriers and enablers to the use of advanced diabetes technologies among individuals with T1D and to synthesise these determinants using the ...
Laura Palermo, Joyeuse Senga, Patience Fakembe, Xi Zhu, Chris Walsh, Brenna Leslie, Rayzel Shulman, Justin Presseau, Maman Joyce Dogba, Ananya Banerjee, Rémi Rabasa‐Lhoret, Meranda Nakhla, Anne‐Sophie Brazeau, Leif Erik Lovblom, Holly O. Witteman, Lorraine L. Lipscombe, Alanna Weisman   +16 more
wiley   +1 more source

Incidence of diabetic ketoacidosis in patients with type 2 diabetes [PDF]

, 2016
Dijabetička ketoacidoza je jedna od najopasnijih akutnih komplikacija šećerne bolesti te može rezultirati visokom stopom smrtnosti ako nije odgovarajuće ili na vrijeme liječena.
Gašpar, Martina
core   +2 more sources

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Evidence on cardiovascular/renal outcomes associated with GLP‐1‐based therapies in type 1 diabetes (T1D) is limited. We examined the effects of GLP‐1‐based therapy on major clinical outcomes and safety, including diabetic ketoacidosis (DKA) and hypoglycemia risk, in adults with T1D in a large real‐world cohort.
Anastasios Tentolouris, Charalampos Filippatos, Nikolaos‐Iason Tepetes, Maria Gavriatopoulou, Evangelos Terpos, Alexandros Briasoulis, Kimon Stamatelopoulos, Theodosios Filippatos   +7 more
wiley   +1 more source